Left ventricle
The thick-walled pressure pump: it fills with oxygenated blood from the left atrium and squeezes hard enough to drive that blood around the entire body.
What it normally does
Its wall is two to three times thicker than the right ventricle's — roughly 6 to 10 mm at end-diastole, against an RV free wall of 3 to 5 mm — because it ejects into a high-pressure circuit. The aortic valve opens once left ventricular pressure climbs above aortic diastolic pressure, about 80 mmHg, and ventricular pressure then peaks around 120 mmHg in ejection; the right ventricle opens its valve at a pulmonary artery diastolic pressure of about 10 mmHg and peaks at only about 25 mmHg. Built for pressure, the left ventricle answers a pressure load by thickening its wall and a volume load by dilating its cavity.
the same organ gives two opposite pictures — hypertension or aortic stenosis thickens the wall inwards onto a small cavity, while a leaking valve or lost muscle stretches the cavity out.
It holds about 120 mL at end-diastole and ejects about 70 mL of that each beat. The fraction it ejects (ejection fraction, EF) is normally about 55 to 70%, and it is a ratio, not a volume — a big floppy ventricle can eject a near-normal volume with a poor fraction, and a small stiff one can eject a small volume with a high fraction.
the ejection fraction alone never tells you whether the patient is in heart failure, and a falling stroke volume — not a falling EF — is what the body misreads as blood loss and answers with neurohormonal activation.
Filling is active work, not passive dropping-in: the muscle has to relax and untwist, which consumes ATP, and it can only happen in diastole. Left ventricular myocardium is also perfused almost entirely in diastole, when the muscle is relaxed and not squeezing its own vessels. Anything that stiffens the muscle or shortens diastole (a fast heart rate) therefore cuts both filling and coronary supply, and roughly a fifth to a quarter of end-diastolic volume in a stiff ventricle comes from atrial contraction.
tachycardia and the loss of the atrial kick in atrial fibrillation both tip a stiff ventricle into pulmonary oedema, and a thick ventricle can develop angina on exertion with unobstructed coronary arteries.
Wall stress rises with chamber pressure and with chamber radius and falls with wall thickness (Laplace: stress is proportional to pressure × radius, divided by twice the wall thickness). Of the three terms, thickening the wall is the only one the myocardium itself can change — lowering pressure or radius takes treatment or a smaller load. Dilating does the opposite and drives stress up.
hypertrophy is the wall's own answer to pressure overload, while dilatation is self-feeding — a bigger radius raises wall stress, wall stress raises oxygen demand, and an ischaemic ventricle dilates further.
What goes wrong
- Thickened wall from pressure overload (concentric hypertrophy)← from “Its wall is two to three times thicker than th…”
Chronic high pressure — usually hypertension, sometimes a narrowed aortic valve — means the ventricle must generate more pressure with every beat. New sarcomeres are laid down side by side (in parallel), so the wall thickens inwards and the cavity gets smaller. By Laplace, the thicker wall brings wall stress back down, but the price is a stiff muscle with a small chamber and more myocardium to perfuse.
Pressure load adds sarcomeres in parallel: thick wall, small cavity, S4, undisplaced heaving apex, normal EF.
You would find: A forceful, sustained apex beat that has NOT moved from the fifth intercostal space in the midclavicular line, a fourth heart sound, tall QRS voltages on the ECG (Sokolow-Lyon: S in V1 plus R in V5 or V6 above about 35 mm), and a wall thickness above about 11 mm on echocardiography.
- Failure to fill (diastolic heart failure, HFpEF)← from “Filling is active work, not passive dropping-i…”
A thick, stiff ventricle cannot relax and accept its normal filling volume without the pressure inside it rising. That raised diastolic pressure passes back into the left atrium, then the pulmonary veins, and fluid is forced into the lung interstitium. Squeezing looks adequate — the ejection fraction is preserved — but the pump has failed on the filling side. Tachycardia and the loss of atrial contraction in atrial fibrillation both make it acutely worse because both steal filling time and filling volume.
Normal EF, high filling pressure: stiff ventricle, atrial fibrillation or tachycardia as the trigger, congestion without a dilated chamber.
You would find: Breathlessness on exertion, crackles at the lung bases and raised natriuretic peptides (an NT-proBNP below about 125 ng/L makes chronic heart failure unlikely) in someone whose echocardiogram shows an EF of 50% or more, usually an older patient with long-standing hypertension. A normal EF does not exclude heart failure.
- Failure to empty with a dilated chamber (systolic heart failure, HFrEF)← from “Wall stress rises with chamber pressure and wi…”
Muscle is lost or damaged — most often by myocardial infarction, otherwise by alcohol, viral myocarditis, chemotherapy, or chronic volume overload from a leaking mitral or aortic valve. Stroke volume falls, blood is left behind at the end of each beat, and the chamber stretches. Sarcomeres are added end to end (in series) and the ventricle dilates. By Laplace the bigger radius raises wall stress, which raises oxygen demand and damages more muscle, so the dilatation feeds itself. Ejection fraction falls: at 40% or below this is HFrEF, the group in which the disease-modifying drugs have their clearest mortality evidence, while 41 to 49% is the mildly reduced band (HFmrEF).
Volume load adds sarcomeres in series: dilated chamber, displaced diffuse apex, S3, EF 40% or less, and Laplace makes it self-perpetuating.
You would find: An apex beat displaced laterally and downwards and diffuse rather than sharp, a third heart sound, and an EF of 40% or less on echocardiography. In Australia, chronic valve leak from rheumatic heart disease is a real cause of this picture in young Aboriginal and Torres Strait Islander patients, among whom rates remain among the highest reported in the world — do not assume a dilated ventricle means an old infarct.
- The neurohormonal vicious cycle← from “It holds about 120 mL at end-diastole and ejec…”
When stroke volume falls, the body reads it as blood loss. The sympathetic nervous system and the renin-angiotensin-aldosterone system switch on, holding onto salt and water and constricting arterioles. More volume means more stretch on an already dilated ventricle; tighter arteries mean more pressure to eject against. Angiotensin II and aldosterone also drive fibrosis in the ventricular wall directly, and sustained catecholamine exposure downregulates myocardial beta-1 receptors. Short-term rescue, long-term destruction — which is why the drugs that prolong life in heart failure block these systems rather than whipping the heart harder.
Falling stroke volume is misread as haemorrhage; RAAS and sympathetic activation buy hours and cost years, so the survival drugs are blockers, not stimulants.
You would find: Ankle oedema, a raised jugular venous pressure (visible more than about 3 cm vertically above the sternal angle with the patient reclined at 45 degrees), resting tachycardia and weight gain over days. It also explains why long-term oral inotropic therapy makes people feel better and die sooner — short courses of intravenous inotropes in cardiogenic shock are a different situation — while beta blockade feels worse for the first weeks and prolongs life.
- Angina with a thick ventricle← from “Filling is active work, not passive dropping-i…”
The left ventricle is perfused in diastole, when the muscle is relaxed. A hypertrophied wall has more muscle to feed, higher intramural pressure squeezing its own vessels, capillary density that has not kept pace with the added muscle, and a shorter diastole once the rate climbs on exertion. The innermost layer, the subendocardium, is last in line and starves first.
Supply-demand angina without coronary stenosis: thick wall, short diastole, subendocardium first to go.
You would find: Exertional chest tightness in someone with aortic stenosis or long-standing hypertension, sometimes with angiographically normal coronary arteries; ECG changes are typically deepest in the leads facing the thickest wall.
What we give, and how it works
Open a drug to see what it binds, what that does to the cell, and what you then see in the patient.
- Binds
- angiotensin-converting enzyme on vascular endothelium (ACE inhibitors), or the AT1 receptor on vascular smooth muscle and adrenal cortex (ARBs)
- Which does
- less angiotensin II is made, or it cannot occupy AT1, so Gq-driven vasoconstriction, aldosterone release and pro-fibrotic signalling in myocardium and vessel wall all fall
- So you see
- afterload falls, salt and water are retained less, and over months the dilated ventricle remodels favourably with better survival
- And the same mechanism causes
- hyperkalaemia and a rise in creatinine — both are the renal consequence of the very blockade that helps the ventricle; and for ACE inhibitors specifically, bradykinin-mediated dry cough and, rarely, angioedema
- Handling
- the same efferent-arteriolar effect makes them hazardous in bilateral renal artery stenosis and in volume depletion, where glomerular filtration depends on that constriction
Catches people out: Blocking angiotensin II dilates the efferent arteriole and drops glomerular filtration pressure, so creatinine rises modestly (a rise up to about 30% that then plateaus is expected, not a reason to abandon the drug) and potassium rises because aldosterone falls — both need checking after starting or uptitrating. Contraindicated in pregnancy: fetal renal maldevelopment and oligohydramnios. The dry cough reflects bradykinin accumulation, since ACE is also kininase II, and is much less common with the receptor blockers, which do not inhibit that enzyme. Angioedema is rare but the same bradykinin story; because sacubitril/valsartan adds neprilysin inhibition to that pathway, a 36-hour gap is observed between an ACE inhibitor and starting it.
- Binds
- beta-1 adrenoceptors on ventricular myocytes and sinoatrial nodal cells (carvedilol also alpha-1 and beta-2)
- Which does
- less Gs-coupled cAMP, so less protein kinase A phosphorylation of L-type calcium channels and phospholamban — contractility and heart rate fall, and chronic catecholamine-driven myocyte injury and receptor downregulation are interrupted
- So you see
- slower rate, longer diastole, lower oxygen demand, and over months a smaller ventricle with a higher ejection fraction and better survival
- And the same mechanism causes
- bradycardia and acute worsening of failure on initiation — the direct result of removing the sympathetic support the failing ventricle has been leaning on
- Handling
- abrupt cessation after chronic use risks rebound tachycardia and ischaemia from upregulated receptors, so they are withdrawn gradually
Catches people out: These are introduced at low dose and uptitrated slowly; starting or increasing one in a patient who is congested and decompensated worsens them, because taking sympathetic drive away from a failing pump makes it worse before it makes it better. Bradycardia, fatigue and hypotension during uptitration are the expected costs.
- Binds
- mineralocorticoid (aldosterone) receptors in the distal nephron and in cardiac fibroblasts
- Which does
- aldosterone cannot drive its transcriptional programme, so epithelial sodium channel expression falls in the nephron and pro-fibrotic collagen signalling falls in the myocardium
- So you see
- a modest natriuresis with potassium retention, less ventricular fibrosis, and a clear mortality benefit in HFrEF
- And the same mechanism causes
- hyperkalaemia, the direct mirror of blocking aldosterone-driven potassium excretion; and for spironolactone, gynaecomastia from its off-target androgen receptor blockade
- Handling
- renal function and potassium are the limiting factors, so the drug becomes progressively less usable as eGFR falls
Catches people out: Stacked on an ACE inhibitor or ARB, both drugs raise potassium, and hyperkalaemia is the thing that actually hurts people here — more so as renal function falls. Spironolactone is not selective and also antagonises androgen receptors and has progestogenic activity, so gynaecomastia, breast tenderness and menstrual disturbance are common; eplerenone is far more selective and much less likely to cause this, though not entirely free of it.
- Binds
- SGLT2 in the S1/S2 segment of the proximal tubule
- Which does
- sodium and glucose reabsorption is blocked at the tubule's high-capacity site, so more sodium reaches the macula densa and glucose is lost in the urine
- So you see
- gentle natriuresis and plasma volume reduction with less congestion, fewer heart failure hospitalisations and lower cardiovascular mortality across the EF spectrum, plus slowed decline in renal function
- And the same mechanism causes
- genital mycotic infection from the glycosuria the drug deliberately creates, and euglycaemic ketoacidosis because urinary glucose loss shifts metabolism towards ketones while keeping blood glucose readings normal
Catches people out: Originally a diabetes drug, but the heart failure benefit is present without diabetes and does not depend on glucose lowering. Genital and perineal fungal infection is common because glucose is being poured into the urine. Euglycaemic diabetic ketoacidosis is the dangerous one — ketoacidosis with a blood glucose that looks reassuring — and the recognised triggers are acute illness, prolonged fasting, low-carbohydrate states and surgery, which is why temporary withholding around those events is standard.
- Binds
- the NKCC2 co-transporter in the thick ascending limb
- Which does
- sodium, potassium and chloride reabsorption is blocked, the medullary concentration gradient collapses, and the extra sodium delivered distally drags potassium, hydrogen, calcium and magnesium out with the water
- So you see
- a brisk diuresis with rapid relief of pulmonary and peripheral congestion
- And the same mechanism causes
- hypokalaemia and metabolic alkalosis with hypomagnesaemia and hypocalcaemia — all the direct consequence of blocking that one transporter and delivering sodium distally — plus ototoxicity with rapid high-dose infusion, since the same transporter operates in the stria vascularis of the inner ear
- Handling
- gut wall oedema in decompensated failure impairs oral absorption, which is why the intravenous route is used when a patient is congested
Catches people out: It makes people feel better and has not been shown to prolong life. It treats the congestion, not the pump — chasing oedema with ever-larger doses instead of establishing the disease-modifying drugs is a classic error. Over-diuresis drops the preload a stiff ventricle depends on and produces hypotension and a rising creatinine.
Look at the apex beat before you look at the echo report. Forceful but not displaced means a pressure-loaded, thickened ventricle — think hypertension or aortic stenosis, and expect a preserved ejection fraction with failure to fill. Displaced laterally and diffuse means a volume-loaded, dilated ventricle — think old infarct or a leaking valve, and expect an ejection fraction of 40% or less. Same symptom of breathlessness, two opposite ventricles — and it is the reduced-EF ventricle that has four drug classes (RAAS blocker, beta blocker, mineralocorticoid receptor antagonist, SGLT2 inhibitor) with proven survival benefit, while in the preserved-EF ventricle only the SGLT2 inhibitor has clear randomised support.
Now test whether it stuck
Reading this through is not the same as being able to reconstruct it. Every question in the bank is free, with a full debrief on each option.